Cargando…

Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques

BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Munigunti, Ranjith, Gathiaka, Symon, Acevedo, Orlando, Sahu, Rajnish, Tekwani, Babu, Calderón, Angela I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828397/
https://www.ncbi.nlm.nih.gov/pubmed/24209891
http://dx.doi.org/10.1186/1752-153X-7-175
_version_ 1782291241598189568
author Munigunti, Ranjith
Gathiaka, Symon
Acevedo, Orlando
Sahu, Rajnish
Tekwani, Babu
Calderón, Angela I
author_facet Munigunti, Ranjith
Gathiaka, Symon
Acevedo, Orlando
Sahu, Rajnish
Tekwani, Babu
Calderón, Angela I
author_sort Munigunti, Ranjith
collection PubMed
description BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant (W2) strains of Plasmodium falciparum through an in vitro assay and also for analysis of non-covalent interactions with P. falciparum thioredoxin reductase (PfTrxR) through in silico docking studies. RESULTS: The inhibitors of PfTrxR namely, 1,4-NQ, 4-NBT and MD displayed significant antimalarial activity with IC(50) values of < 20 μM and toxicity against 3T3 cell line. 2,4-DNPS was only moderately active. In silico docking analysis of these compounds with PfTrxR revealed that 2,4-DNPS, 4-NBT and MD interact non-covalently with the intersubunit region of the enzyme. CONCLUSIONS: In this study, tools for the identification of PfTrxR inhibitors using phenotyphic screening and docking studies have been validated for their potential use for antimalarial drug discovery project.
format Online
Article
Text
id pubmed-3828397
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38283972013-11-15 Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques Munigunti, Ranjith Gathiaka, Symon Acevedo, Orlando Sahu, Rajnish Tekwani, Babu Calderón, Angela I Chem Cent J Research Article BACKGROUND: The compounds 1,4-napthoquinone (1,4-NQ), bis-(2,4-dinitrophenyl)sulfide (2,4-DNPS), 4-nitrobenzothiadiazole (4-NBT), 3-dimethylaminopropiophenone (3-DAP) and menadione (MD) were tested for antimalarial activity against both chloroquine (CQ)-sensitive (D6) and chloroquine (CQ)-resistant (W2) strains of Plasmodium falciparum through an in vitro assay and also for analysis of non-covalent interactions with P. falciparum thioredoxin reductase (PfTrxR) through in silico docking studies. RESULTS: The inhibitors of PfTrxR namely, 1,4-NQ, 4-NBT and MD displayed significant antimalarial activity with IC(50) values of < 20 μM and toxicity against 3T3 cell line. 2,4-DNPS was only moderately active. In silico docking analysis of these compounds with PfTrxR revealed that 2,4-DNPS, 4-NBT and MD interact non-covalently with the intersubunit region of the enzyme. CONCLUSIONS: In this study, tools for the identification of PfTrxR inhibitors using phenotyphic screening and docking studies have been validated for their potential use for antimalarial drug discovery project. BioMed Central 2013-11-10 /pmc/articles/PMC3828397/ /pubmed/24209891 http://dx.doi.org/10.1186/1752-153X-7-175 Text en Copyright © 2013 Munigunti et al.; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Munigunti, Ranjith
Gathiaka, Symon
Acevedo, Orlando
Sahu, Rajnish
Tekwani, Babu
Calderón, Angela I
Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
title Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
title_full Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
title_fullStr Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
title_full_unstemmed Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
title_short Characterization of PfTrxR inhibitors using antimalarial assays and in silico techniques
title_sort characterization of pftrxr inhibitors using antimalarial assays and in silico techniques
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828397/
https://www.ncbi.nlm.nih.gov/pubmed/24209891
http://dx.doi.org/10.1186/1752-153X-7-175
work_keys_str_mv AT muniguntiranjith characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques
AT gathiakasymon characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques
AT acevedoorlando characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques
AT sahurajnish characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques
AT tekwanibabu characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques
AT calderonangelai characterizationofpftrxrinhibitorsusingantimalarialassaysandinsilicotechniques